Health Technology · Pharmaceuticals: Major · NSE: SHILPAMED · data 2026-10-09
Shilpa Medicare Limited
Health check: Average (6.3/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹1,021.7
Market cap
₹20,072 cr
P/E
67.2
P/B
—
ROE
9.8%
ROCE
9.0%
Debt / equity
0.25
Dividend yield
0.06%
1-year return
181.5%
52-week high
₹1,095
52-week low
₹259.5
Operating margin
21.0%
Growth
| Revenue (last 12 months) | ₹1,682 cr |
| Net profit (last 12 months) | ₹297 cr |
| Sales growth, 3 years (yearly) | 13.8% |
| Profit growth, 3 years (yearly) | — |
Chart patterns
- Ascending triangle — forming (key level ₹1,095)
Similar companies
Caplin Point Laboratories Limited (CAPLIPOINT) · PFIZER LIMITED (PFIZER) · OneSource Specialty Pharma Limited (ONESOURCE) · Cohance Lifesciences Ltd (COHANCE) · Alivus Life Sciences Ltd (ALIVUS)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SHILPAMED in NSE Scanner →